PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
35605662-0	2022	Selective PPARdelta agonist seladelpar suppresses bile acid synthesis by reducing hepatocyte CYP7A1 via the fibroblast growth factor 21 signaling pathway.	Seladelpar	28-38	fibroblast growth factor 21	Mus musculus	108-135	
35605662-5	2022	In addition, seladelpar upregulated fibroblast growth factor 21 (Fgf21) in mouse liver, serum, and in cultured hepatocytes.	Seladelpar	13-23	fibroblast growth factor 21	Mus musculus	36-63	
35605662-5	2022	In addition, seladelpar upregulated fibroblast growth factor 21 (Fgf21) in mouse liver, serum, and in cultured hepatocytes.	Seladelpar	13-23	fibroblast growth factor 21	Mus musculus	65-70	
35605662-7	2022	The suppressive effect of seladelpar on Cyp7a1 expression was blocked by a JNK inhibitor as well as in the absence of Fgf21, indicating that Fgf21 plays an indispensable role in PPARdelta-mediated downregulation of Cyp7a1.	Seladelpar	26-36	fibroblast growth factor 21	Mus musculus	141-146